Metap Inc.: Announcing the New Project "Metaverse x GameFi", Whitelist and Community Registration Campaign Is Underway!
16.12.2021 09:24:00 EET | Business Wire | Press release
Gensokishi Online has announced the release of its official website "Gensokishi Online -META WORLD-" in Dec. 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211215006137/en/
Gensokishi Online -Meta World- (Graphic: Business Wire)
This project is a new version of "Gensokishi Online", which won the "Game of the year, Gold Award" in 2012 in Taiwan and has been played by a total of 8 million users. Gensokishi aims to build a new fantasy world economy with blockchain technology, incorporating NFT and GameFi elements into a 3D MMO world metaverse.
"Gensokishi Online", a Japanese 3D MMO title licensed from "Elemental Knights Online", has been trusted and proven for more than 13 years on various apps, Nintendo Switch and PlayStation4.
In the world created by WEB3.0, Metaverse, and GameFi, Gensokishi will realize the three features of "Free to Play", "Play to Earn", and "UGC to Earn".
Anyone can create an account for free and buy and sell the NFT items and tokens they acquire.
In the future, Genoskishi plans to offer "UGC (User Generated Contents)," which will allow users and companies to create and sell NFT items, as well as the right to freely create land, place objects, natural environments, characters, and monsters in the metaverse.
Gensokishi operates on top of Polygon (MATIC), better known as an Ethereum based protocol that allows players to get the benefits of high transaction capabilities and low costs.
Furthermore, this initiative also includes participation from key personalities in the video game industry.
The MV token will be on Uniswap on Dec. 23, 2021. For more information, please see the white paper.
About the Campaign
Various campaigns are being held to celebrate the announcement of Gensokishi Online.
Community Registration Campaign
A campaign is currently being held to distribute "Limited Equipment NFT" to all those who join the community by Dec. 27, 2021.
Whitelist
Starting Dec. 7, Gensokishi is running a $10,000 Whitelist Campaign, and if you enter by Dec. 19, you will be entitled to purchase up to $100 worth of token at private sale prices.
Official Community
Twitter
Telegram
Discord
Service Outline
Description: Gensokishi Online -META WORLD-
Languages: English, Chinese, Japanese
System Requirements: PC, Android, iOS
Source : Taiwan Gensokishi Online Project Metap.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211215006137/en/
Contact information
Metap Inc.
Maxi Kuan
Phone number: +886935312638
E-mail address: info@genso.game
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GenBio AI Builds First World Model of the Human Cell18.8.2026 16:00:00 EEST | Press release
GenBio AI ('GenBio') is an AI for Science company co-founded by Nobel Laureate David Baker, leading AI scientist Eric Xing, and other prominent life science and artificial intelligence researchers from Stanford, Carnegie Mellon University, Mohamed Bin Zayed University of Artificial Intelligence, Harvard, Weizmann Institute, and other research institutions. Today, the company introduced AIDO Cell, its virtual cell world model — the first system capable of simulating a human cell, both in its natural state and in response to drugs and other interventions, across its full biological hierarchy, from DNA and RNA through protein to the whole-cell level. A Key First in Biological and Medical Sciences: Full-hierarchy virtual cell simulation has been widely identified as a key milestone in computational biology. Compared to the previous efforts by various research labs, AIDO Cell is the first to integrate the entire molecular-to-cellular spectrum into one continuous simulation. Using the system
Xsolla Partner Network Expands Verified Creator Partnerships and Unifies Campaign Management Ahead of gamescom 202618.8.2026 16:00:00 EEST | Press release
Xsolla, a global video game commerce company, today announced an expansion of the Xsolla Partner Network ahead of gamescom 2026 in Cologne, giving game developers a simpler, more reliable way to grow their games through creators. The creator platform now lives within Xsolla Publisher Account, where developers already run their business, with verified creator onboarding and a redesigned and unified campaign workflow. Flat-fee campaigns, a new guaranteed payment option alongside revenue share, and data-driven creator recommendations are coming soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818140062/en/ Graphic: Xsolla Xsolla Partner Network gives developers one place to launch, manage, track, and report on creator campaigns while Xsolla handles payments, payouts, taxes, and compliance. Verified creators, less guesswork. Automated anti-fraud vetting and identity verification at payout means developers partner with rea
KOCCA to Showcase 13 Korean Game Companies at ‘Gamescom 2026’ with PC, Mobile, and VR Lineups18.8.2026 15:48:00 EEST | Press release
The Korea Creative Content Agency (KOCCA) announced that 13 Korean game companies will gather under one roof at Gamescom 2026, Europe’s largest game show, held in Cologne, Germany, from August 26 to 28 (B2B, 09:00~20:00). Located in Booth Hall 3.2 C-050g–D051g, the Korea Joint Pavilion offers visitors hands-on experiences with an expansive lineup of titles, ranging from PC and mobile games to VR-powered titles across diverse genres. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818271881/en/ KOCCA will bring 13 Korean game companies to Gamescom 2026 in Cologne, Germany (Image: KOCCA) The standout feature of this year’s joint pavilion is its overwhelming genre diversity. The lineup includes roguelike deckbuilders, visual novels, 2D shooters, rhythm action, and cooperative horror survival—catering to a broad spectrum of gamers—alongside immersive content that integrates AI and XR technology. Introducing the Participating T
SLB to Support Offshore Production Restoration for Brunei Shell Petroleum18.8.2026 15:06:00 EEST | Press release
Global energy technology company SLB (NYSE: SLB) today announced it has been awarded a contract by Brunei Shell Petroleum (BSP) to support production restoration from shut-in wells across multiple offshore fields. The contract scope spans subsurface evaluation, well candidate selection, engineering and offshore execution. Project management, intervention services, monitoring, metering and marine logistics are integrated within a single coordinated execution model designed to support efficient production restoration. “Building on our long collaboration in the region, this contract reflects a shared commitment to maximizing value from existing offshore resources,” said Gokhan Yarim, senior vice president of Integration, SLB. “Together with BSP, we are combining SLB’s production expertise and integrated execution capabilities to help restore production from shut-in wells, increase recovery from existing infrastructure and support BSP’s long-term production objectives.” The project marks t
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries18.8.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership through 2028 to expand access to BRUKINSA® (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively. Building on a collaboration launched in 2023, the renewed partnership reflects the organizations’ shared commitment to improving access to innovative cancer treatments in underserved communities. To date, the partnership has enabled access to BRUKINSA for more than 300 patients with CLL across Armenia, Ethiopia, and Nepal, exceeding the program’s original scope by approximately 150 patients and helping establish access to innovative cancer care for patients who previo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom